Kieran F Scott Selected Research

Circulating Neoplastic Cells

1/2022	Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells.
1/2020	The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kieran F Scott Research Topics

Disease

13	Neoplasms (Cancer) 04/2023 - 10/2004
10	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 10/2004
9	Inflammation (Inflammations) 04/2023 - 01/2005
6	Rheumatoid Arthritis 10/2021 - 01/2003
3	Asthma (Bronchial Asthma) 04/2010 - 01/2003
2	Circulating Neoplastic Cells 01/2022 - 01/2020
2	Infections 11/2021 - 01/2008
2	Carcinogenesis 04/2021 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 04/2021 - 01/2021
2	Atherosclerosis 06/2013 - 04/2010
2	Neoplasm Metastasis (Metastasis) 08/2006 - 10/2004
2	Hypersensitivity (Allergy) 01/2005 - 01/2003
2	Urticaria (Hives) 01/2005 - 01/2003
2	Chronic Renal Insufficiency 01/2005 - 01/2003
1	Colonic Neoplasms (Colon Cancer) 04/2022
1	Glioma (Gliomas) 04/2021
1	Brain Neoplasms (Brain Tumor) 04/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Frailty 01/2021
1	Disease Progression 01/2020
1	Gout 06/2013
1	Rheumatic Diseases (Rheumatism) 06/2013
1	Necrosis 01/2012
1	Cystic Fibrosis (Mucoviscidosis) 04/2010

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2010
6	EnzymesIBA 04/2023 - 10/2004
6	AndrogensIBA 01/2023 - 10/2004
6	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2013 - 01/2003
4	Arachidonic Acid (Vitamin F)IBA 01/2017 - 10/2004
4	Phospholipases (Phospholipase)IBA 01/2011 - 10/2004
3	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2020
3	Secretory Phospholipases A2IBA 11/2021 - 10/2004
3	EicosanoidsIBA 01/2021 - 10/2004
2	PlatinumIBA 04/2023 - 09/2022
2	Cisplatin (Platino)FDA LinkGeneric 09/2022 - 04/2022
2	SalicylatesIBA 10/2021 - 01/2003
2	Hypochlorous Acid (Hypochlorite)IBA 10/2021 - 06/2013
2	CytokinesIBA 01/2012 - 01/2011
2	Phospholipases A2 (Phospholipase A2)IBA 06/2010 - 08/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2006 - 10/2004
2	Lipoxygenase (Lipoxygenase-1)IBA 08/2006 - 10/2004
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2005 - 01/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2023
1	QuercetinIBA 01/2023
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2023
1	ResveratrolIBA 01/2023
1	CurcuminIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	indole-3-carbinolIBA 01/2023
1	GenisteinIBA 01/2023
1	EquolIBA 01/2023
1	PhytochemicalsIBA 01/2023
1	ProdrugsIBA 09/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2022
1	Chlorambucil (Leukeran)FDA Link 09/2022
1	Immune Checkpoint InhibitorsIBA 03/2022
1	AntibodiesIBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 10/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	Group II Phospholipases A2IBA 01/2017
1	hypobromous acidIBA 06/2013
1	VimentinIBA 05/2013
1	Lipase (Acid Lipase)FDA Link 05/2013
1	LipidsIBA 06/2010
1	Oxidants (Oxidizing Agents)IBA 04/2010
1	Heparitin Sulfate (Heparan Sulfate)IBA 04/2010
1	Small Interfering RNA (siRNA)IBA 12/2008
1	Hormones (Hormone)IBA 12/2008
1	Group IV Phospholipases A2IBA 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2008
1	Annexin A1IBA 08/2006

Therapy/Procedure

4	Therapeutics 04/2021 - 10/2004
1	Drug Therapy (Chemotherapy) 04/2023
1	Immunotherapy 03/2022
1	Castration 01/2022
1	Oral Surgery (Maxillofacial Surgery) 01/2005
1	Aftercare (After-Treatment) 10/2004